Research Collaborations

Please contact us if you have samples that you would like to characterize via the Insight TNBCtype™.

Insight Genetics has a number of ongoing research studies to advance the clinical understanding of Insight TNBCtype.

 This includes:

  • Sponsored research project to identify novel biomarkers in TNBC
  • In silico proof-of-concept studies have shown agreement with expected results in all scenarios tested to date. More information can be found here.
  • Clinical studies with key opinion leaders

Insight Genetics also has a keen interest in the following therapeutic research areas and is looking for unique opportunities to collaborate.

  • PARP inhibitors (Basal-like subtypes)
  • mTOR/PI3K Inhibitors (Mesenchymal subtypes)
  • Androgen Receptor Therapies (LAR subtype)
  • Immuno-Oncology Therapies (IM modifier)

Please contact us if you’d like to join us in our mission to better understand and treat TNBC.